Tandem Diabetes Care (TNDM) Other Operating Expenses (2013 - 2025)

Tandem Diabetes Care (TNDM) posted Other Operating Expenses of $75.2 million for Q1 2025, up 7521800.0% on a QoQ basis from -$1000.0 in Q4 2024.

Tandem Diabetes Care (TNDM) Other Operating Expenses (2013 - 2025) Analysis & Trends

Tandem Diabetes Care's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $75.2 million for Q1 2025.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $75.2 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $75.2 million (up 7521800.0% YoY) and the FY2025 annual result came in at $75.2 million, changed N/A from the prior year.
  • Other Operating Expenses was $75.2 million for Q1 2025 at Tandem Diabetes Care, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $78.8 million in Q1 2023 and bottomed at -$1000.0 in Q4 2024.
  • A 4-year average of $37.0 million and a median of $31.0 million in 2022 frame the typical range for Other Operating Expenses.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Tandem Diabetes Care 1.17 Bn 597.96 Mn 136.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 75.22 Mn
Dec 31, 2024 -1,000.00
Mar 31, 2023 78.75 Mn
Dec 31, 2022 23,000.00
Sep 30, 2022 31.02 Mn
Dec 31, 2019 -1,000.00
Dec 31, 2017 -1,000.00
Dec 31, 2014 1,000.00
Jun 30, 2014 -1,000.00
Dec 31, 2013 2.00
Sep 30, 2013 -379.00
Jun 30, 2013 -70.00
Mar 31, 2013 446.00